8-KThe WireRed Alert
Executive Change · Reg FD Disclosure
Filed Sep 14, 2022 · 3y ago · Accession 0001171843-22-006097
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- BIOCRYST PHARMACEUTICALS INC
- Ticker
- BCRX
- CIK
- 882796
- Form type
- 8-K
- Filing date
- Sep 14, 2022
- Report date
- Sep 9, 2022
- Document
- f8k_091422.htm
- Size
- 216 KB